Hui‐Tzu Tu

1.3k total citations
32 papers, 858 citations indexed

About

Hui‐Tzu Tu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Hui‐Tzu Tu has authored 32 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 5 papers in Surgery. Recurrent topics in Hui‐Tzu Tu's work include Atrial Fibrillation Management and Outcomes (21 papers), Cardiac Arrhythmias and Treatments (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Hui‐Tzu Tu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (21 papers), Cardiac Arrhythmias and Treatments (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Hui‐Tzu Tu collaborates with scholars based in Taiwan, United Kingdom and United States. Hui‐Tzu Tu's co-authors include Shang‐Hung Chang, Lai‐Chu See, Yung‐Hsin Yeh, Yi‐Hsin Chan, Chi‐Tai Kuo, Lung‐Sheng Wu, Hsin‐Fu Lee, Chang‐Fu Kuo, Yu‐Tung Huang and Chun‐Li Wang and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Stroke.

In The Last Decade

Hui‐Tzu Tu

31 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Tzu Tu Taiwan 14 685 336 112 76 72 32 858
Emilio Poggio United States 7 597 0.9× 212 0.6× 67 0.6× 278 3.7× 74 1.0× 10 905
Gregory Y H Lip United Kingdom 13 863 1.3× 287 0.9× 141 1.3× 89 1.2× 49 0.7× 41 963
A. Groth Germany 12 386 0.6× 117 0.3× 125 1.1× 53 0.7× 82 1.1× 25 626
F J van der Meer Netherlands 9 423 0.6× 335 1.0× 96 0.9× 91 1.2× 24 0.3× 13 777
Bcps United States 5 724 1.1× 508 1.5× 172 1.5× 136 1.8× 8 0.1× 48 985
Kristine Hommel Denmark 12 864 1.3× 371 1.1× 236 2.1× 51 0.7× 39 0.5× 25 1.2k
Xianying Pan United States 14 922 1.3× 470 1.4× 146 1.3× 65 0.9× 14 0.2× 30 1.1k
Yasuhiro Hamatani Japan 17 845 1.2× 145 0.4× 226 2.0× 85 1.1× 17 0.2× 87 973
Khagendra Dahal United States 15 434 0.6× 133 0.4× 78 0.7× 196 2.6× 93 1.3× 57 779
Yihong Sun China 14 421 0.6× 55 0.2× 133 1.2× 188 2.5× 117 1.6× 76 733

Countries citing papers authored by Hui‐Tzu Tu

Since Specialization
Citations

This map shows the geographic impact of Hui‐Tzu Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Tzu Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Tzu Tu more than expected).

Fields of papers citing papers by Hui‐Tzu Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Tzu Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Tzu Tu. The network helps show where Hui‐Tzu Tu may publish in the future.

Co-authorship network of co-authors of Hui‐Tzu Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Tzu Tu. A scholar is included among the top collaborators of Hui‐Tzu Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Tzu Tu. Hui‐Tzu Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Victor Chien‐Chia, Chun‐Li Wang, Yu‐Chang Huang, et al.. (2024). Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study. Journal of the American Heart Association. 13(21). e033513–e033513. 2 indexed citations
2.
Wu, Victor Chien‐Chia, Yu‐Chang Huang, Hui‐Tzu Tu, et al.. (2023). Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants. EP Europace. 25(5). 5 indexed citations
3.
Huang, Yu‐Tung, Victor Chien‐Chia Wu, Hui‐Tzu Tu, et al.. (2023). Surgical volume and outcomes of surgical ablation for atrial fibrillation: a nationwide population-based cohort study. BMC Cardiovascular Disorders. 23(1). 84–84. 2 indexed citations
4.
Chen, Chiung‐Mei, Kuo‐Hsuan Chang, Chunli Wang, et al.. (2022). Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics. Frontiers in Pharmacology. 13. 819878–819878. 3 indexed citations
5.
Wu, Victor Chien‐Chia, Chunli Wang, Hui‐Tzu Tu, et al.. (2022). Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study. Frontiers in Cardiovascular Medicine. 9. 934193–934193. 7 indexed citations
6.
Wu, Hsin‐Hsu, Shang‐Hung Chang, Tsong‐Hai Lee, et al.. (2022). Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study. Frontiers in Cardiovascular Medicine. 9. 969259–969259. 10 indexed citations
7.
Chang, Kuo‐Hsuan, Chiung‐Mei Chen, Chunli Wang, et al.. (2022). Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants. Frontiers in Aging Neuroscience. 14. 791285–791285. 13 indexed citations
8.
Cheng, Yu‐Ting, Yu‐Tung Huang, Hui‐Tzu Tu, et al.. (2022). Long-term Outcomes of Concomitant Surgical Ablation for Atrial Fibrillation. The Annals of Thoracic Surgery. 116(2). 297–305. 8 indexed citations
9.
Wang, Chunli, Victor Chien‐Chia Wu, Hui‐Tzu Tu, et al.. (2021). Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation. Journal of Thrombosis and Thrombolysis. 53(3). 633–645. 12 indexed citations
10.
Ray, C.H., Victor Chien‐Chia Wu, Chunli Wang, et al.. (2021). Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors. Frontiers in Pharmacology. 12. 570835–570835. 5 indexed citations
11.
Wu, Victor Chien‐Chia, Chunli Wang, Yu‐Tung Huang, et al.. (2021). Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT. Atherosclerosis. 324. 76–83.
12.
Wu, Victor Chien‐Chia, Chun‐Li Wang, Cheng‐Hung Lee, et al.. (2020). Novel Oral Anticoagulant vs. Warfarin in Elderly Atrial Fibrillation Patients with Normal, Mid-Range, and Reduced Left Ventricular Ejection Fraction. ESC Heart Failure. 7(5). 2862–2870. 3 indexed citations
13.
Chan, Yi‐Hsin, Hsin‐Fu Lee, Lai‐Chu See, et al.. (2019). Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. CHEST Journal. 156(3). 529–543. 98 indexed citations
14.
Chan, Yi‐Hsin, Yung‐Hsin Yeh, Chia‐Yu Chang, et al.. (2018). The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan. International Journal of Cardiology. 265. 83–89. 35 indexed citations
15.
See, Lai‐Chu, Shao‐Hsuan Hsia, Hui‐Tzu Tu, et al.. (2018). Pediatric abusive head trauma in Taiwan: clinical characteristics and risk factors associated with mortality. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(5). 997–1003. 13 indexed citations
16.
Chan, Yi‐Hsin, Yung‐Hsin Yeh, Lai‐Chu See, et al.. (2016). Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin. Journal of the American College of Cardiology. 68(21). 2272–2283. 60 indexed citations
17.
Lee, Hsin‐Fu, Lung‐Sheng Wu, Yi‐Hsin Chan, et al.. (2016). Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study. PLoS ONE. 11(1). e0146343–e0146343. 8 indexed citations
18.
Chan, Yi‐Hsin, Chi‐Tai Kuo, Yung‐Hsin Yeh, et al.. (2016). Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology. 68(13). 1389–1401. 138 indexed citations
19.
Huang, Wen‐Kuan, Hui‐Tzu Tu, & Lai‐Chu See. (2015). Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence. Current Pharmaceutical Design. 21(35). 5108–5115. 9 indexed citations
20.
See, Lai‐Chu, et al.. (2013). Adult Out-of-Hospital Cardiac Arrest Based on Chain of Survival in Taoyuan County, Northern Taiwan. Journal of Emergency Medicine. 46(6). 782–790. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026